Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbalife Q3

This article was originally published in The Tan Sheet

Executive Summary

Net sales for the third quarter were up 18.8% over the prior-year period to $476.4 mil., largely attributable to revenue increases in the U.S. (up 24.7%) and Mexico (up 66%), Herbalife announces Nov. 8. New products launched during the quarter included a water-mixable version of the Formula 1 protein drink and a reformulated version of the Garden 7 phytonutrient supplement. The firm opened five stores in China, bringing its presence in that country to 33 stores in 20 provinces. Greater China accounted for 7.6% of worldwide sales, contributing $36.2 mil. during the quarter. The company expects net sales growth of 18%-20% during the fourth quarter...

You may also be interested in...



Noncompliance Issues In Mexico Lead To Decreased Growth For Herbalife

Herbalife announces Jan. 4 it lowered its 2007 sales growth expectations because of problems in Mexico, including noncompliance issues

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

International Harmonization: Not Just For Audits Anymore

The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel